• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

SANOFI (SAN)

SANOFI
Sell: €74.00|Buy: €75.00|Change: 1.21 (-1.61%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Address

54, Rue La Boetie
Paris
FRA
75008

Telephone

+33 153774000

Website

https://www.sanofi.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Sanofi SA Second Quarter Earnings Conference Call for 20272027-07-30T07:00:00
Sanofi SA Second Quarter Earnings Results for 20272027-07-30T00:00:00
Sanofi SA Annual General Meeting for 20272027-04-29T00:00:00
Sanofi SA First Quarter Earnings Conference Call for 20272027-04-23T07:00:00
Sanofi SA First Quarter Earnings Results for 20272027-04-23T00:00:00
Sanofi SA Annual Report for 20262027-02-18T00:00:00
Sanofi SA Fourth Quarter Earnings Conference Call for 20262027-01-29T08:30:00
Sanofi SA Fourth Quarter Earnings Results for 20262027-01-29T00:00:00
Sanofi SA Third Quarter Earnings Results for 20262026-10-30T07:30:00
Sanofi SA Third Quarter Earnings Conference Call for 20262026-10-30T00:00:00

Previous key dates

NameKey Date
Sanofi SA Second Quarter Earnings Conference Call for 20262026-07-30T07:00:00
Sanofi SA Second Quarter Earnings Result for 20262026-07-30T00:00:00
Sanofi SA Annual General Meeting for 20262026-04-29T00:00:00
Sanofi SA First Quarter Earnings Conference Call for 20262026-04-23T07:00:00
Sanofi SA First Quarter Earnings Result for 20262026-04-23T00:00:00
Sanofi SA Annual Report for 20252026-02-18T00:00:00
Sanofi SA Fourth Quarter Earnings Conference Call for 20252026-01-29T08:30:00
Sanofi SA Fourth Quarter Earnings Result for 20252026-01-29T00:00:00
Sanofi SA Third Quarter Earnings Conference Call for 20252025-10-24T08:30:00
Sanofi SA Third Quarter Earnings Results for 20252025-10-24T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.